Experimental heart treatment tested during stent procedures
NCT ID NCT04327635
Summary
This early-stage study tested the safety of a biological drug called PEP, made from parts of donated blood, in people who had just received a heart stent. The drug was injected directly into the heart's arteries during the stent procedure to see if it could help slow or stop heart damage. Nine patients were enrolled and followed for one year to check for any safety issues.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERCUTANEOUS CORONARY INTERVENTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.